Businesses
Here's a look at documents from U.S. and international businesses
Featured Stories
Next Episode: India Has Achieved an Electrification Miracle. Now It's Writing Its Wind Story
CAMBRIDGE, Massachusetts, Dec. 13 -- G.E. Vernova, an energy company, posted the following news release:
* * *
Next Episode: India Has Achieved an Electrification Miracle. Now It's Writing Its Wind Story.
In 2010, India's grid was in crisis. The Asian nation struggled with power deficits close to 13% during periods of peak demand, while around one in four Indians still lacked access to electricity. But India has come a long way, and fast. Today 99.6% of Indians have electricity access. Given that the country's population is almost 1.5 billion, these achievements are nothing short of a modern
... Show Full Article
CAMBRIDGE, Massachusetts, Dec. 13 -- G.E. Vernova, an energy company, posted the following news release:
* * *
Next Episode: India Has Achieved an Electrification Miracle. Now It's Writing Its Wind Story.
In 2010, India's grid was in crisis. The Asian nation struggled with power deficits close to 13% during periods of peak demand, while around one in four Indians still lacked access to electricity. But India has come a long way, and fast. Today 99.6% of Indians have electricity access. Given that the country's population is almost 1.5 billion, these achievements are nothing short of a modernmiracle. But India isn't stopping there.
"Almost everyone now has access to power," says Deepak Maloo, who heads up GE Vernova's Onshore Wind business in India and the Asia Pacific region. "Now they want 24/7 supply." To achieve reliable, round-the-clock power that can support its rapidly growing economy, India plans to double its power capacity to almost 900 gigawatts (GW) by 2030. It also has a mission to power its future with clean, sustainable energy. It is seeking to install 500 GW of "non-fossil fuel" power capacity by 2030, which would include renewables, large hydropower dams, and nuclear plants.
It might sound like a tall order, but India has Mother Nature on its side. Some Indian regions, like the sandy flats of Gujarat, receive more than eight hours of sunshine per day. Monsoons gust back and forth over India's long coastline, which extends over 6,900 miles (11,000 kilometers) from the Arabian Sea to the Bay of Bengal. The elements work together to India's advantage, with sunny days and windy nights. "That allows for round-the-clock renewable power," says Maloo.
India also plans to write its own renewables story. It is seeking to manufacture the thousands of wind turbines and millions of solar panels required for its upcoming electrification needs domestically, rather than import ready-made power plants. Since 2014, its government has championed a Make in India initiative, which encourages investments in India's domestic manufacturing sector to boost GDP, increase its economic independence, and create millions of new jobs. There's a mantra, too: "We say 'Atmanirbhar Bharat,' which means 'self-reliant India," explains Maloo.
Work in Progress
India has already written the first chapter in the story. The country now boasts more than 50 GW of wind power capacity -- more power than is found on the entire Argentine grid. A poster child of India's "first 50 GW" was a GE Vernova onshore wind turbine, designed for the country's low wind speeds and vast expanses.
India was the hero of that story, too: The turbine, which can generate 2.7 MW, was homemade, from start to finish. The concept was hatched at GE Vernova's engineering and design hub in Bengaluru, while factories in Gujarat ("one of India's biggest," says Maloo) and Karnataka made the turbine's blades. A plant in Maharashtra assembled the nacelle, the giant box that houses the turbine's critical machinery, such as the gearbox, generator, and electronic controls.
These shop floors teem with homegrown talent. For example, the Maharashtrian city of Pune has forged a reputation as "the Oxford of the East" for its many excellent universities. "They help provide us with fresh talent in different areas like manufacturing, services, operations, or maintenance," says Maloo.
The Road to 500 Gigawatts
But with its breezy landscapes capable of supporting up to 200 GW, India has only scratched the surface of its wind power potential. "Land is also becoming more constrained, so we want high-performing, high-capacity-factor turbines," says Maloo. Fortunately, GE Vernova boasts an even larger onshore turbine that's ready to pick up the mantle and propel India to its 500-GW target.
It's capable of generating 3.8 MW, which is enough electricity to supply the equivalent of 30,800 Indian households. What's more, it's already the most tested wind turbine in GE Vernova history, and up and spinning in the U.S. Maloo explains that the Asian country imposes fewer tip height restrictions, which allows for a taller hub height. These larger dimensions help to shrink a wind farm's total footprint, he says. A typical onshore wind farm of 300 MW now requires just 79 next-generation turbines, rather than 112 with the previous model.
Like its predecessor, the supersize turbine will also be homemade. In addition to its engineering hubs, blade shops, and assembly lines, GE Vernova is collaborating with manufacturers in several Indian states to make its turbine tower, which shortens the journey of the huge components to their destined wind farm. The reliance on homegrown companies will push the "local content" value of GE Vernova's wind turbine manufacturing operations well over 70%, says Maloo. This highlights GE Vernova's unwavering dedication to bolstering local industries while simultaneously driving forward innovative renewable energy solutions in India.
The engineer notes that the made-in-India movement is a two-way street. While manufacturers adhere to stringent local content rules, they receive a huge prize in return: access to the mighty Indian market. "In some European countries, a large equipment manufacturer might install 500 megawatts a year," says Maloo. "In India, we're talking about 6 gigawatts."
GE Vernova is ready to seize the opportunity. It has been present in India since 1902, when it constructed Asia's first hydroelectric power station at Shivanasamudra Falls, near Mysore, which generated power for the region's gold mines. Today the company has 11 manufacturing sites, five technology and engineering centers, and a workforce of more than 10,000 employees.
While they'll be standing on their own two feet, they won't be alone: GE Vernova will use all its scale, experience, and knowledge, with a presence in more than 50 countries and a total installed base of 57,000 wind turbines, to support them every step of the way. "Our people can deliver what India is looking for," says Maloo. "That's reliability, quality, and uniformity at scale."
* * *
Original text here: https://www.gevernova.com/news/articles/next-episode-india-has-achieved-electrification-miracle-now
[Category: BizEnergy]
Independence Blue Cross Announces Coupe Health, a New Health Plan Option Designed to Provide Cost Certainty, Affordability, and Quality
PHILADELPHIA, Pennsylvania, Dec. 13 -- Independence Blue Cross, a subsidiary of Independence Health Group, issued the following news release:
* * *
Independence Blue Cross announces Coupe Health, a new health plan option designed to provide cost certainty, affordability, and quality
Plan boasts 9-10 percent reduction in employer and member health plan costs
*
Independence Blue Cross (IBX) announces Coupe Health/* (Coupe), a health plan that provides cost certainty, affordability, and transparent provider quality. Coupe is designed with both employers and employees in mind, offering significant
... Show Full Article
PHILADELPHIA, Pennsylvania, Dec. 13 -- Independence Blue Cross, a subsidiary of Independence Health Group, issued the following news release:
* * *
Independence Blue Cross announces Coupe Health, a new health plan option designed to provide cost certainty, affordability, and quality
Plan boasts 9-10 percent reduction in employer and member health plan costs
*
Independence Blue Cross (IBX) announces Coupe Health/* (Coupe), a health plan that provides cost certainty, affordability, and transparent provider quality. Coupe is designed with both employers and employees in mind, offering significantsavings and fostering a simpler, more user-friendly experience. The plan is available starting January 1, 2026, for IBX self-funded large employers (51+).
"At Independence Blue Cross, we are committed to delivering innovative solutions that empower both employers and employees and help them thrive. The launch of Coupe Health reflects our dedication to providing a clear, straightforward health care experience--one where members can confidently manage their out-of-pocket expenses and avoid unexpected costs, and employers can manage their health care expenses with greater predictability and ease," said Susan Larkin, Independence Blue Cross executive vice president and chief commercial officer.
How Coupe's simple, user-friendly model differs from other health plans
- Price certainty. Coupe makes health care similar to other online shopping experiences. The plans have no coinsurance or deductible for all benefits, including out-of-network providers. Since costs are set in advance, members will know exactly what they'll pay before receiving care - eliminating potentially complicated bills./**
- Quality-ranked providers. Providers are ranked and categorized as green, yellow, or red with green providers offering the highest quality at the lowest cost using the BlueCross BlueShield Association's negotiated rates and national dataset - the largest commercial dataset in the industry.
- Seamless user experience. The Coupe app and member site offer easy access to the provider search tool, benefits information, and provider rankings. Members can look up providers and services in the Coupe app or member portal to view copays before using them.
- Personalized support. Health Valets are available to guide members through their health care journey and answer questions.
Savings for employers and members/***
On average, employers and members who select Coupe have seen a 9-10 percent reduction in health plan costs. In addition, 92 percent of members surveyed say they'd keep their Coupe health plan over their previous health plan.
To learn more about Coupe Health, visit ibx.com/employers or call 1-888-475-6206 (TTY: 711).
* * *
*/ Coupe Health, LLC is an independent company that provides benefit design services.
**/ When members see an out-of-network provider, balance billing is used.
***/ Based on Coupe Health book of business
* * *
Original text here: https://news.ibx.com/coupe-health-plan/
[Category: BizInsurance]
Flying Into the End Zone: Delta Adds College Football Playoff Game Flights
ATLANTA, Georgia, Dec. 13 -- Delta Air Lines issued the following news:
* * *
Flying into the end zone: Delta adds college football playoff game flights
Delta is adding additional flights for the College Football Playoff quarterfinals and building off the airline's well-positioned existing network to ensure fans can be there to cheer on their team.
*
College football fans, get ready to pack your bags and your team spirit; Delta has your ticket to cheer on your favorite team in the biggest games of the season.
"Bowl season is all about tradition, rivalries and unforgettable moments as teams
... Show Full Article
ATLANTA, Georgia, Dec. 13 -- Delta Air Lines issued the following news:
* * *
Flying into the end zone: Delta adds college football playoff game flights
Delta is adding additional flights for the College Football Playoff quarterfinals and building off the airline's well-positioned existing network to ensure fans can be there to cheer on their team.
*
College football fans, get ready to pack your bags and your team spirit; Delta has your ticket to cheer on your favorite team in the biggest games of the season.
"Bowl season is all about tradition, rivalries and unforgettable moments as teamsbattle it out for a place in the championship," said Amy Martin, Vice President - Network Planning. "By adding additional flights and building off Delta's well-positioned existing network, we are making sure college football fans can be there to cheer on their team when and where it matters the most."
Here's where Delta is adding extra lift for the College Football Playoff quarterfinals:
Wednesday, Dec. 31
Dallas
* Buckeye fans, Delta has you covered with flights from Columbus (CMH) to Dallas (DFW) on Dec. 30 and Jan. 1.
Thursday, Jan. 1
Miami
* Delta is adding flights between Atlanta (ATL) to Miami (MIA), offering 12 daily segments on Dec. 31 and Jan. 2 to give customers additional flight options down to Miami.
Los Angeles
* Hoosier Nation: Delta is adding an extra Indianapolis (IND) to Los Angeles (LAX) flights on Dec. 30, Dec. 31 and Jan. 2.
New Orleans
* Dawgs fans, Delta is turning up the volume: Atlanta (ATL) to New Orleans (MSY) gets additional flights Dec. 31 and Jan. 2.
Pro tip: These flights will go fast, so book early and make sure you're in the stands when history happens.
Our full added schedule can be viewed below:
CMH-DFW Adds
Flight Number ... Date ... Departure Airport ... Departure Time ... Arrival Airport ... Arrival Time ... Aircraft
DL 8801 ... 30-Dec-25 ... CMH ... 10:30 ... DFW ... 12:30 ... Boeing 737-900
DL 8801 ... 1-Jan-26 ... DFW ... 13:35 ... CMH ... 17:15 ... Boeing 737-900
ATL-MIA Adds
Flight Number ... Date ... Departure Airport ... Departure Time ... Arrival Airport ... Arrival Time ... Aircraft
DL 8801 ... 31-Dec-25 ... ATL ... 12:00 ... MIA ... 13:53 ... Boeing 737-900
DL 8811 ... 2-Jan-26 ... MIA ... 15:05 ... ATL ... 17:10 ... Boeing 757D
IND-LAX Adds
Flight Number ... Date ... Departure Airport ... Departure Time ... Arrival Airport ... Arrival Time ... Aircraft
DL 8804 ... 30-Dec-25 ... IND ... 10:30 ... LAX ... 12:13 ... Boeing 737-900
DL 8804 ... 31-Dec-25 ... IND ... 10:30 ... LAX ... 12:13 ... Boeing 737-900
DL 8801 ... 2-Jan-26 ... LAX ... 12:00 ... IND ... 18:58 ... Boeing 737-900
DL 8804 ... 2-Jan-26 ... LAX ... 13:00 ... IND ... 19:58 ... Boeing 737-900
ATL-MSY Adds
Flight Number ... Date ... Departure Airport ... Departure Time ... Arrival Airport ... Arrival Time ... Aircraft
DL 8800 ... 31-Dec-25 ... ATL ... 11:49 ... MSY ... 12:30 ... Boeing 737-900
DL 8902 ... 31-Dec-25 ... ATL ... 12:25 ... MSY ... 13:06 ... Boeing 737-900
DL 8810 ... 2-Jan-26 ... MSY ... 9:19 ... ATL ... 11:44 ... Boeing 757D
DL 8812 ... 2-Jan-26 ... MSY ... 14:35 ... ATL ... 17:04 ... Boeing 757D
Hoping to watch the games, but have a flight scheduled during the action? Delta has got you covered there, too. With much of the airline's fleet equipped with live satellite TV, customers can enjoy the games from the comfort of their seat on flights while over the Continental U.S. Customers traveling on aircraft equipped with Delta Sync Wi-Fi can also use the streaming-quality connectivity to access their own subscription services and seamlessly stream the games. Delta has reached another major industry milestone with the installation of fast, free Delta Sync Wi-Fi presented by T-Mobile on its 1,000th aircraft, representing approximately 75% of the total fleet.
* * *
Original text here: https://news.delta.com/flying-end-zone-delta-adds-college-football-playoff-game-flights
[Category: BizTravel]
Depemokimab Receives Positive CHMP Opinion for Severe Asthma With Type 2 Inflammation and Chronic Rhinosinusitis With Nasal Polyps
LONDON, England, Dec. 13 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release on Dec. 12, 2025:
* * *
Depemokimab receives positive CHMP opinion for severe asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps
- If approved, depemokimab will be the first and only ultra-long-acting biologic in the EU to treat respiratory diseases
- Positive opinion based on four phase III trials with statistically significant and clinically meaningful primary endpoints across severe asthma and chronic rhinosinusitis with nasal polyps (CRSwNP)
-
... Show Full Article
LONDON, England, Dec. 13 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release on Dec. 12, 2025:
* * *
Depemokimab receives positive CHMP opinion for severe asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps
- If approved, depemokimab will be the first and only ultra-long-acting biologic in the EU to treat respiratory diseases
- Positive opinion based on four phase III trials with statistically significant and clinically meaningful primary endpoints across severe asthma and chronic rhinosinusitis with nasal polyps (CRSwNP)
-In Europe, an estimated 3 million people live with severe asthma and patients with CRSwNP face poorly controlled symptoms
*
GSK plc (LSE/NYSE: GSK) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of depemokimab in two indications:
- as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by blood eosinophil count in adults and adolescents 12 years and older who are inadequately controlled despite high dose inhaled corticosteroids (ICS) plus another asthma controller;
- as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with severe CRSwNP for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control.
The European Commission decision on approval is expected in Q1 2026.
The positive opinion is based on data from the SWIFT and ANCHOR phase III trials which showed sustained efficacy with a twice-yearly dosing regimen for depemokimab. Each of the four trials met their primary or co-primary endpoints with statistically significant and clinically meaningful results, comparing the addition of depemokimab to standard of care versus standard of care alone. The trials support the potential for depemokimab to provide ultra-long-acting protection from asthma exacerbations as well as to alleviate symptoms associated with CRSwNP in just two doses a year./1,2
Kaivan Khavandi, SVP & Global Head, Respiratory, Immunology & Inflammation R&D, GSK said: "Many patients with severe asthma continue to face frequent exacerbations, hospital visits and exposure to chronic oral corticosteroids, highlighting the need for new therapies that deliver durable control with less treatment burden. Today's positive CHMP opinion means that depemokimab could become the first and only ultra-long-acting biologic approved in Europe for the treatment of severe asthma with type 2 inflammation and CRSwNP. In just two doses a year, depemokimab could help redefine care for millions of patients."
Asthma affects more than 42 million people in Europe./3 About 5-10% of patients experience severe asthma, and many continue to experience exacerbations and reduced quality of life despite treatment./4 Depemokimab's sustained suppression of type 2 inflammation has the potential to address the underlying drivers of additional diseases such as CRSwNP, helping to alleviate associated symptoms. /5-7
The pooled results from SWIFT showed a 54% reduction in clinically significant exacerbations (asthma attacks) over 52 weeks [rate ratio 0.46, 95% confidence interval (0.36, 0.59), nominal p<0.001] (AER depemokimab = 0.51 exacerbations per year versus placebo = 1.11)./1 Additionally, this pooled analysis showed a 72% reduction [RR 0.28, 95% CI (0.13, 0.61), nominal p=0.002] (AER: depemokimab = 0.02 versus placebo = 0.09) in the secondary endpoint of clinically significant exacerbations requiring hospitalisation or emergency department visit compared to placebo./1 In AGILE, an open-label 12-month extension study, depemokimab maintained the results seen in SWIFT-1 and SWIFT-2, confirming the sustained safety and efficacy of a twice-yearly dose of depemokimab over the course of two years.
Pooled results from the ANCHOR trials showed an improvement (reduction) from baseline in nasal polyp score (scale: 0-8) at 52 weeks [treatment difference -0.7, 95% CI (-0.9, -0.4), nominal p<0.001] and in nasal obstruction verbal response scale (scale: 0-3) over weeks 49-52 [treatment difference -0.24, 95% CI (-0.39, -0.08), nominal p=0.003]./2
Across these trials, depemokimab was well-tolerated, with patients experiencing a similar rate and severity of side effects as those receiving placebo./1,2
About the SWIFT phase III trials
Results from the SWIFT trials were presented at the 2024 European Respiratory Society International Conference and published in the New England Journal of Medicine.
The SWIFT-1 and SWIFT-2 clinical trials assessed the efficacy and safety of depemokimab adjunctive therapy in 382 and 380 participants with severe asthma who were randomised to receive depemokimab or a placebo respectively, in addition to their standard of care (SOC) treatment with medium to high-dose inhaled corticosteroids plus at least one additional controller. The full analysis set in SWIFT-1 included 250 patients in the depemokimab plus SOC arm and 132 in the placebo plus SOC arm; in SWIFT-2, 252 patients were included in the depemokimab plus SOC arm and 128 in the placebo plus SOC arm./1
* * *
About the ANCHOR phase III trials
Results from the ANCHOR trials were presented at the 2025 American Academy of Allergy, Asthma and Immunology (AAAAI) and World Allergy Organization (WAO) Joint Congress and published in The Lancet.
ANCHOR-1 included 143 patients in the depemokimab plus SOC arm and 128 in the placebo plus SOC arm; in ANCHOR-2, 129 patients were included in the depemokimab plus SOC arm and 128 in the placebo plus SOC arm. All 528 patients had inadequately controlled CRSwNP, including nasal polyps in both nasal cavities (an endoscopic bilateral NPS 5), and had either undergone previous surgery for CRSwNP, had received previous treatment with SCS or were intolerant to SCS. Patients received depemokimab or placebo at six-monthly intervals (26 weeks) in addition to SOC (maintenance intranasal corticosteroids).2
* * *
About depemokimab
Depemokimab is the first ultra-long-acting biologic being evaluated for certain respiratory diseases with underlying type 2 inflammation, such as severe asthma and CRSwNP. It combines high interleukin-5 (IL-5) binding affinity and high potency with an extended half-life to enable twice-yearly dosing.1,2 IL-5 is a key cytokine in type 2 inflammation./8
Depemokimab is currently not approved anywhere in the world.
* * *
About GSK in respiratory
GSK continues to build on decades of pioneering work to deliver more ambitious treatment goals, develop the next generation standard of care, and redefine the future of respiratory medicine for hundreds of millions of people with respiratory diseases. With an industry-leading respiratory portfolio and pipeline of vaccines, targeted biologics, and inhaled medicines, GSK is focused on improving outcomes and the lives of people living with all types of asthma and COPD along with less understood refractory chronic cough or rarer conditions like systemic sclerosis with interstitial lung disease. GSK is harnessing the latest science and technology with the aim of modifying the underlying disease dysfunction and preventing progression.
* * *
About GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at gsk.com.
* * *
Cautionary statement regarding forward-looking statements
GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described in the "Risk Factors" section in GSK's Annual Report on Form 20-F for 2024, and GSK's Q3 Results for 2025.
* * *
References
1./ Jackson D., et al. Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype. NEJM. September 2024. Vol. 391 No. 24.DOI: 10.1056/NEJMoa2406673.
2./ Gevaert, Philippe et al. Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials. The Lancet, Volume 405, Issue 10482, 911 - 926. DOI: 10.1016/S0140-6736(25)00197-7.
3./ International Respiratory Coalition. Asthma. Available at: https://international-respiratory-coalition.org/diseases/asthma/. Accessed December 2025.
4./ Wang E, et al. Characterization of Severe Asthma Worldwide: Data From the International Severe Asthma Registry. CHEST, Volume 157, Issue 4, 790 - 804. https://doi.org/10.1016/j.chest.2019.10.053.
5./ Laidlaw TM, et al. Chronic rhinosinusitis with nasal polyps and asthma. J Allergy Clin Immunol. 2021;147(2):603-609. DOI: 10.1016/j.jaip.2020.09.063.
6./ Joustra, Gonneke E et al. "Long-term clinical control in chronic rhinosinusitis: Outcomes more than five years after surgery." European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery vol. 282,9 (2025): 4661-4668. DOI:10.1007/s00405-025-09529-z.
7./ Fokkens WJ, et al. EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy, Volume 74, Issue 12, 2312 - 2319. DOI: 101.1111/all.13875
8./ "What Is Type 2 Inflammation?" Allergy & Asthma Network, 22 May 2025, allergyasthmanetwork.org/health-a-z/type-2-inflammation-resources/.
* * *
Original text here: https://www.gsk.com/en-gb/media/press-releases/depemokimab-receives-positive-chmp-opinion-for-severe-asthma-with-type-2-inflammation/
[Category: BizPharmaceuticals]
Boston Consulting Group: U.S. Luxury and Exotic Car Market Set to Reach Up to $215 Billion by 2035--Nearly Twice Its Current Size
BOSTON, Massachusetts, Dec. 13 (TNSrpt) -- Boston Consulting Group, a management consulting firm, presented the following news release:
* * *
US Luxury and Exotic Car Market Set to Reach Up to $215 Billion by 2035--Nearly Twice Its Current Size
* New BCG and duPont REGISTRY Study Explores How Luxury Car Brands Can Adapt to Fading Loyalty, Changing Digital Habits, and Shifting Ownership Expectations
* Secondary Market for Luxury and Exotic Vehicles Projected to Grow 1.5x Faster Than New Sales Over the Next Decade
* Emotion Ranked as the Top Driver of Luxury Vehicle Purchases
* 95% of Buyers
... Show Full Article
BOSTON, Massachusetts, Dec. 13 (TNSrpt) -- Boston Consulting Group, a management consulting firm, presented the following news release:
* * *
US Luxury and Exotic Car Market Set to Reach Up to $215 Billion by 2035--Nearly Twice Its Current Size
* New BCG and duPont REGISTRY Study Explores How Luxury Car Brands Can Adapt to Fading Loyalty, Changing Digital Habits, and Shifting Ownership Expectations
* Secondary Market for Luxury and Exotic Vehicles Projected to Grow 1.5x Faster Than New Sales Over the Next Decade
* Emotion Ranked as the Top Driver of Luxury Vehicle Purchases
* 95% of BuyersSaid Experiences Enhanced Their Brand Satisfaction
*
The US luxury and exotic car market is projected to grow from $110 billion today to between $180 and $215 billion by 2035. The strongest growth is expected in vehicles priced between $100,000 and $170,000--both new and used--with annual sales forecast to rise 6% to 8%. In contrast, slower growth is expected in the higher-margin "ultra-luxury" and "hyper-luxury" segments (vehicles priced at $170,000 and above).
Rising new car prices, driven by higher production costs and tariff impacts, combined with a growing pool of secondary market inventory, are pushing more buyers toward pre-owned models. Sales of used luxury and exotic cars are expected to grow 1.5 times faster than new car sales over the next decade, rising 5% to 8% annually compared to 5% to 6% for new vehicles.
These are among the findings of a new report from Boston Consulting Group (BCG) and duPont REGISTRY Group , titled Beyond the Drive: The Future of the Luxury Automotive Ecosystem . The report draws on a survey of over 400 current owners, former owners, and prospective buyers; interviews with leading dealers, collectors, and auto executives; and a proprietary market-sizing model.
"Luxury is no longer defined solely by the vehicle itself," said Antoine Tessier, CEO of duPont REGISTRY Group, and a coauthor of the report. "Today's buyers demand more than exceptional engineering--they expect a curated journey. From personalized digital touchpoints to exclusive, in-person experiences, the buying process has become as critical as the car. For modern collectors, that elevated experience is the true mark of luxury."
How Luxury Buyers Shop Today
* Shopping is a near-constant activity. About 80% of buyers browse online for luxury vehicles weekly or even daily, even when they don't have an immediate intention to purchase.
* Younger buyers cross-shop more broadly than other generations. Although most buyers stick to a few preferred brands, millennials and Gen Z respondents are more likely to explore.
* Emotion drives purchasing across generations. One in three buyers cited emotional factors, such as a connection to the brand or design, as their top reason for choosing a car. Beyond emotion, buyers aged 18 to 60 were more likely to view a luxury car as a reward or investment opportunity. Buyers aged 60 and above cited cutting-edge technology and owning the latest model as key motivations.
* Buyers act fast once they've decided. Although most buyers (69%) spend over three months researching, one-third complete a purchase within a week of deciding on a vehicle. Another third buy within two to four weeks.
* Digital platforms are rising in influence. While most sales still happen through dealerships, three-quarters of respondents said they would consider buying their next vehicle entirely online. Millennials and Gen Z were more likely to buy from digital platforms or private sellers (mainly conducted online).
Experiences, Events, and Services Now Central to Luxury Car Ownership
Nearly 95% of respondents said experiences are a valuable part of their brand satisfaction, but not all experiences are rated equally. Driving-focused events such as track days, factory tours, and driver training were most popular, whereas lifestyle experiences like wine tastings or fashion events were nascent but significant.
When it comes to services, the three most essential were vehicle pick-up and drop-off, quick resolution of minor issues, and a dedicated advisor. Despite this, about 60% of buyers said they hadn't purchased an all-in-one service package along with their vehicle, with two-thirds saying it either wasn't offered or was too expensive.
"Luxury auto brands are entering an era where heritage alone won't be enough," said Felix Stellmaszek, global leader of BCG's Automotive and Mobility practice, and a coauthor of the report. "The next wave of growth will come from brands that elevate the entire experience and collaborate with the right partners in the ecosystem--bringing the same dedication they've long given to engineering and design to the immersive ownership experiences today's buyers expect. This is the moment to lead by making luxury more personal and seamless."
* * *
About duPont REGISTRY Group (DRG)
duPont REGISTRY Group (DRG) is the world's leading luxury automotive ecosystem, encapsulating the culture, community and commerce of the high-end automotive lifestyle. For more than 40 years, DRG has served as a trusted source for the vibrant global community of members looking to buy and sell luxury vehicles. Using data insights and advanced technology to build a seamless and scalable digital marketplace, duPont REGISTRY Group facilitates billions of dollars in transactions and redefines how enthusiasts and collectors engage within the luxury automotive world. Its portfolio includes duPont REGISTRY , Canossa Events , Cavallino , Supercar Owners Circle , Petrolicious , Retromobile USA , FerrariChat , and Sotheby's Motorsport . For more information, visit www.duPontREGISTRYGroup.com.
* * *
About Boston Consulting Group
Boston Consulting Group partners with leaders in business and society to tackle their most important challenges and capture their greatest opportunities. BCG was the pioneer in business strategy when it was founded in 1963. Today, we work closely with clients to embrace a transformational approach aimed at benefiting all stakeholders--empowering organizations to grow, build sustainable competitive advantage, and drive positive societal impact.
Our diverse, global teams bring deep industry and functional expertise and a range of perspectives that question the status quo and spark change. BCG delivers solutions through leading-edge management consulting, technology and design, and corporate and digital ventures. We work in a uniquely collaborative model across the firm and throughout all levels of the client organization, fueled by the goal of helping our clients thrive and enabling them to make the world a better place.
* * *
REPORT: https://web-assets.bcg.com/a5/35/bcc2e69f477bb7f53403ebd097ba/the-future-of-the-luxury-automobile-ecosystem-dec2025.pdf
* * *
Original text here: https://www.bcg.com/press/12december2025-us-luxury-exotic-car-market
[Category: BizConsulting]
Alphabet Inc. Issues Commentary: You Can Now Have More Fluid and Expressive Conversations When You Go Live With Search
MOUNTAIN VIEW, California, Dec. 13 -- Alphabet Inc. a provider of internet services (Google), issued the following commentary on Dec. 12, 2025:
* * *
You can now have more fluid and expressive conversations when you go Live with Search.
By Liza Ma | Director, Product Management, Search
When you go Live with Search, you can have a back-and-forth voice conversation in AI Mode to get real-time help and quickly find relevant sites across the web. And now, thanks to our latest Gemini model for native audio, the responses on Search Live will be more fluid and expressive than ever before.
This update
... Show Full Article
MOUNTAIN VIEW, California, Dec. 13 -- Alphabet Inc. a provider of internet services (Google), issued the following commentary on Dec. 12, 2025:
* * *
You can now have more fluid and expressive conversations when you go Live with Search.
By Liza Ma | Director, Product Management, Search
When you go Live with Search, you can have a back-and-forth voice conversation in AI Mode to get real-time help and quickly find relevant sites across the web. And now, thanks to our latest Gemini model for native audio, the responses on Search Live will be more fluid and expressive than ever before.
This updatemeans that Search can respond with a more natural sounding voice or at a certain speed - perfect for DIY help or learning more about a new topic, like geology. Just open the Google app (Android & iOS), tap the Live icon under the search bar and ask your question out loud for a helpful audio response.
The updated Gemini model for native audio will roll out over the next week to all Search Live users in the U.S. We hope you'll try it out soon to enjoy smoother, more natural conversations.
* * *
Original text here: https://blog.google/products/search/live-audio-gemini-model-update/
Alphabet Inc. Issues Commentary: Bringing State-Of-The-Art Gemini Translation Capabilities to Google Translate
MOUNTAIN VIEW, California, Dec. 13 -- Alphabet Inc. a provider of internet services (Google), issued the following commentary on Dec. 12, 2025:
* * *
Bringing state-of-the-art Gemini translation capabilities to Google Translate
By Rose Yao, VP, Product, Search
We're bringing Gemini's most powerful translation capabilities to Google Translate for text, launching a beta experience for live speech-to-speech translations with headphones, and adding new languages to the app for practice and skill building.
True understanding comes from not just what someone says, but also the nuance of how they
... Show Full Article
MOUNTAIN VIEW, California, Dec. 13 -- Alphabet Inc. a provider of internet services (Google), issued the following commentary on Dec. 12, 2025:
* * *
Bringing state-of-the-art Gemini translation capabilities to Google Translate
By Rose Yao, VP, Product, Search
We're bringing Gemini's most powerful translation capabilities to Google Translate for text, launching a beta experience for live speech-to-speech translations with headphones, and adding new languages to the app for practice and skill building.
True understanding comes from not just what someone says, but also the nuance of how theysay it. Today, Google Translate is getting better at both.
We're introducing state-of-the-art text translation quality 1 in Search and the Translate app, built with Gemini. This means you'll get much smarter, more natural and accurate text translations wherever you're searching. We're also rolling out a new beta version of live translation, that brings real-time, natural-sounding translations right to your headphones with the help of Gemini's new, native speech-to-speech translation capabilities. Plus, we're adding more languages for you to practice in the Translate app.
Get smarter, more natural translations, built with Gemini
Starting today, Google Translate uses advanced Gemini capabilities to better improve translations on phrases with more nuanced meanings like idioms, local expressions or slang.
Say you're trying to translate an English idiom like "stealing my thunder." Now, it's easier than ever to get a more natural, accurate translation, instead of a literal word-for-word translation. Gemini parses the context to give you a helpful translation that captures what the idiom really means.
This update is rolling out starting today in the U.S. and India translating between English and nearly 20 languages, including Spanish, Hindi, Chinese, Japanese and German, in the Translate app (Android and iOS) and on the web.
Hear and understand the world in real-time
Building on Gemini's new live speech-to-speech translation capabilities, we are rolling out a beta experience enabling you to hear real-time translations in your headphones. This new experience works to preserve the tone, emphasis and cadence of each speaker to create more natural translations and make it easier to follow along with who said what. Whether you're trying to have a conversation in a different language, listen to a speech or lecture while abroad, or watch a TV show or film in another language, you can now put in your headphones, open the Translate app, tap "Live translate" and hear a real-time translation in your preferred language.
Following positive feedback in early testing, we're excited to make this beta more broadly available to collect even more feedback as we work to refine the model and experience. Starting today the beta is rolling out in the Translate app on Android in the U.S., Mexico, and India, works with any pair of headphones, and supports more than 70 languages. And we'll be bringing it to iOS and more countries in 2026. Try it out in the Android app and let us know your thoughts via in-app feedback!
Practice and master even more languages in Translate
Starting today, we're also expanding our language learning tools in the Translate app with improved feedback so you can get helpful tips based on your speaking practice. We're also introducing a way for you to challenge yourself and reach your learning goals by tracking how many days in a row you've been learning, so you can clearly see your progress and consistency over time.
And we're expanding the capability to nearly 20 new countries including Germany, India, Sweden, and Taiwan, so even more people can continue to refine their language skills, including:
* English to German and Portuguese
* Bengali, Mandarin Chinese (Simplified), Dutch, German, Hindi, Italian, Romanian, and Swedish to English
We've heard from users that they appreciate the customized learning experiences that reflect real-life scenarios. We'll continue to add new ways for people to make progress on their language learning goals.
With even more advanced AI models and expanded language learning capabilities in Translate, we're helping you capture not just the words, but the meaning behind them. We're excited to hear what you think.
* * *
Original text here: https://blog.google/products/search/gemini-capabilities-translation-upgrades/
